Influence of HLA-DR antigens on lymphocyte response to Mycobacterium tuberculosis culture filtrate antigens and mitogens in pulmonary tuberculosis

Tubercle and Lung Disease

Volumn 79, Issue 4, 1999, Pages 199-206

  Uma, H ^a   Selvaraj, P ^a   Reetha, A M ^a   Xavier, T ^a   Prabhakar, R ^a   Narayanan, P R ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GENE PRODUCT; HLA DR ANTIGEN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ;

ARTICLE; BACTERIUM CULTURE; IMMUNE RESPONSE; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0032829621     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1999.0211     Document Type: Article

References (30)

1. Dannenberg A M Jr. Pathology of pulmonary tuberculosis. Am Rev Respir Dis. 125:1982;25-29.
2. Unanue E R, Beller D I, Lu C, Allen P M. Antigen presentation: Comments of its regulation and mechanism. J Immunol. 132:1984;1-5.
3. Bendentzen K, Morling N, Fomsgaard A. Association between HLA-DR2 and production of tumour necrosis factor - alpha and interleukin-1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol. 28:1988;599-606.
4. Cox R A, Downs M, Neimes R E, Ognibene A J, Yamashita T S, Ellner J J. Immunogenetic analysis of human tuberculosis. J Infect Dis. 158:1988;1302-1308.
5. Mustafa A S, Lundin K E A, Oftung F. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with M. bovis BCG and M. leprae. Infect Immun. 61:1993;5294-5301.
6. Benacerraf B. Role of MHC gene products in immune regulation. Science. 212:1981;1229-1238.
7. de Vries R R P. Regulation of T-cell responsiveness against mycobacterial antigens by HLA class 2 immune response genes. Rev Infect Dis. 11:1989;S400-S403.
8. Dausset J. The Major Histocompatibility Complex in man: past, present and future concepts. Science. 213:1981;1469-1474.
9. Bothamley G H, Beck J S, Schreuder G M T. Association of tuberculosis and M. tuberculosis -specific antibody levels with HLA. J Infect Dis. 159:1989;549-555.
10. Khomenko A G, Litvinov V I, Chukanova V P, Pospelov L E. Tuberculosis in patients with various HLA phenotypes. Tubercle. 71:1990;187-192.
11. Brahmajothi V, Pitchappan R M, Kakkanaiah V N. Association of pulmonary tuberculosis and HLA in South India. Tubercle. 72:1991;123-132.
12. Rajalingam R, Mehra N K, Jain R C, Myneedu V P, Pande J N. Polymerase chain reaction based sequence-specific oligonucleotide hybridisation analysis of HLA-Class II antigens in pulmonary tuberculosis: Relevance to chemotherapy and disease severity. J Infect Dis. 173:1996;669-676.
13. Selvaraj P, Uma H, Reetha A M. HLA antigen profile in pulmonary tuberculosis patients and their spouses. Ind J Med Res. 107:1998;155-158.
14. Selvaraj P, Uma H, Reetha A M, Xavier T, Prabhakar R, Narayanan P R. Influence of HLA-DR2 phenotype on humoral immunity and lymphocyte response to M. tuberculosis culture filtrate antigens in pulmonary tuberculosis. Indian J Med Res. 107:1998;208-217.
15. Ottenhoff T H M, Torres P, de las Agus J T. Evidence for an HLA-DR4 associated immune-response gene for M. tuberculosis. A clue to the pathogenesis of rheumatoid arthritis. Lancet. II:1986;310-312.
16. Bothamley G H, Gibbs J H, Beck J S. Delayed hypersensitivity and HLA in smear positive pulmonary tuberculosis. Int Arch Allerg Immunol. 106:1995;38-45.
17. Selvaraj P, Reetha A M, Uma H. Influence of HLA-DR and -DQ phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tuberc Lung Dis. 77:1996;369-373.
18. de Vries R R P, Serjeantson S W, Layrisse Z. Albert E D. Histocompatibility testing. 1984;362-367 Springer Verlag, Berlin.
19. Mitra D K, Rajalingam R, Taneja V, Bhattacharyya B C, Mehra N K. HLA-DR polymorphism modulates the cytokine profile of M. leprae HSP-reactive CD4+T cells. Clin Immunol Immunopathol. 82:1997;60-67.
20. Roche P W, Feng C G, Britton W J. Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand J Immunol. 43:1996;662-670.
21. Jurcevic S, Hills A, Pasvol G, Davidson R N, Ivanyi J, Wilkinson R J. T-cell responses to a mixture of M. tuberculosis peptides with complementary HLA-DR binding profiles. Clin Exp Immunol. 105:1996;416-421.
22. Geluk A, van Meijgaarden K E, de Vries R R, Sette A, Ottenhoff T H. A DR17-restricted T-cell epitope from a secreted Mycobacterium tuberculosis antigen only binds to DR17 molecules at neutral pH. Eur J Immunol. 27:1997;842-847.
23. Zhu X, Venkataprasad N. Thangaraj H S et al. Functions and specificity of T cells following nucleic acid vaccination of mice againstMycobacterium tuberculosis infection. J Immunol. 158:1997;5921-5926.
24. Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest. 21:1968;31-50.
25. Terasaki P I, McClelland J D. Microdroplet assay of human serum cytotoxins. Nature. 204:1964;998-1000.
26. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with Folin Phenol reagents. J Biol Chem. 193:1951;265-275.
27. Van Eden W, de Vries R R P, Stanford J L, Rook G A W. HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol. 52:1983;287-292.
28. Ottenhoff T H M, Haanen J B A G, Geluk A. Regulation of mycobacterial heat shock protein reactive T-cells by HLA Class-II molecules: lessons from leprosy. Immunol Rev. 121:1991;171-191.
29. Van Eden E, Elferink B G, Hermans J, De Vries R R P, Van Rood J J. Role of HLA class II products in proliferative T-lymphocyte responses to PPD. Scand J Immunol. 20:1984;503-510.
30. Candore G, Cigna D, Gervasi F, Colicci A T, Modica M A, Caruso C. In vitro cytokine production by HLA-B8, DR3 positive subjects. Autoimmunity. 18:1994;121-132.